Hi, what are you looking for?
– – Please help us out : Will you offer us a hand? Every gift, regardless of size, fuels our future. Your critical contribution...
– Galmed Pharmaceuticals Ltd., a clinical-stage biotech developing therapies for liver diseases and gallstones, filed on Thursday with the SEC to raise up to $35...
– The burn and wound treatment company MediWound plans to raise $100m on Nasdaq at a $400 million valuation. – In the coming weeks, several Israeli...
– The Adverse Event Profile for Rolapitant was Consistent with Earlier Clinical Trials. Preparations Continue in Support of Submission of a New Drug Application...
– Some of the company’s Israeli shareholders having been cashing in on the share’s record price. – David Reis CEO Stratasys – The share...
– Dan Propper, Chairman of the Israeli Osem Group of companies has sold the last of his shares to Swiss company Nestlé. The...
– The network security company’s main patents are about to expire. – Check Point’s founder, chairman and CEO Gil Shwed – / By Shmulik Shelach...
– Perrigo is acquiring Ireland’s Elan, a beneficiary of royalties from rival multiple sclerosis treatment, Tysabri. – – A safety warning by the US...
– The medical devices company plans to raise the money at a company valuation of $500 million by February. – – Sources inform ”Globes”...
– Mooly Eden: Start-ups are fine, but we must attract the multinationals. – – “There is stigma over the tax breaks in the Law...